Rational Design and Expedient Synthesis of Heparan Sulfate Mimetics from Natural Aminoglycosides for Structure and Activity Relationship Studies
- 29 June 2023
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (32) , e202304325
Abstract
Heparan sulfate (HS) contains variably repeating disaccharide units organized into high‐ and low‐sulfated domains. This rich structural diversity enables HS to interact with many proteins and regulate key signaling pathways. Efforts to understand structure‐function relationships and harness the therapeutic potential of HS are hindered by the inability to synthesize an extensive library of well‐defined HS structures. We herein report a rational and expedient approach to access a library of 27 oligosaccharides from natural aminoglycosides as HS mimetics in 7–12 steps. This strategy significantly reduces the number of steps as compared to the traditional synthesis of HS oligosaccharides from monosaccharide building blocks. Combined with computational insight, we identify a new class of four trisaccharide compounds derived from the aminoglycoside tobramycin that mimic natural HS and have a strong binding to heparanase but a low affinity for off‐target platelet factor‐4 protein.Keywords
Funding Information
- National Institute of General Medical Sciences (R01GM136968, R01GM098285)
- Foundation for the National Institutes of Health (S10OD028488)
This publication has 39 references indexed in Scilit:
- Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and MetastasisJournal of Medicinal Chemistry, 2012
- Heparan Sulfate ProteoglycansCold Spring Harbor Perspectives in Biology, 2011
- Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host–cell interactionNature Chemistry, 2011
- Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure−Activity Relationship StudiesJournal of the American Chemical Society, 2009
- PI-88: a novel inhibitor of angiogenesisExpert Opinion on Investigational Drugs, 2008
- Sulfation patterns of glycosaminoglycans encode molecular recognition and activityNature Chemical Biology, 2006
- A Modular Strategy Toward the Synthesis of Heparin-like Oligosaccharides Using Monomeric Building Blocks in a Sequential Glycosylation StrategyJournal of the American Chemical Society, 2005
- Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongationThrombosis and Haemostasis, 2005
- A Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next?Angewandte Chemie International Edition, 2004
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995